130 related articles for article (PubMed ID: 2396362)
21. Systematic single cell analysis of migration and morphological changes of human neutrophils over stimulus concentration gradients.
Yamauchi A; Degawa-Yamauchi M; Kuribayashi F; Kanegasaki S; Tsuchiya T
J Immunol Methods; 2014 Feb; 404():59-70. PubMed ID: 24370750
[TBL] [Abstract][Full Text] [Related]
22. Human monocyte chemotaxis to complement-derived chemotaxins is enhanced by Gc-globulin.
Piquette CA; Robinson-Hill R; Webster RO
J Leukoc Biol; 1994 Mar; 55(3):349-54. PubMed ID: 8120452
[TBL] [Abstract][Full Text] [Related]
23. Quantitative comparisons of various biological responses of neutrophils to different active and inactive chemotactic factors.
Kreutzer DL; O'Flaherty JT; Orr W; Showell HJ; Ward PA; Becker EL
Immunopharmacology; 1978 Dec; 1(1):39-47. PubMed ID: 45788
[TBL] [Abstract][Full Text] [Related]
24. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
Harvath L; Yancey KB; Katz SI
J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092
[TBL] [Abstract][Full Text] [Related]
25. Substance P: a neurogenic mediator of acute cellular inflammation in the dog?
Thomsen MK
J Vet Pharmacol Ther; 1991 Sep; 14(3):250-6. PubMed ID: 1720820
[TBL] [Abstract][Full Text] [Related]
26. Acetyl glyceryl ether phosphorylcholine (PAF-acether) and leukotriene B4-mediated neutrophil chemotaxis through an intact endothelial cell monolayer.
Hopkins NK; Schaub RG; Gorman RR
Biochim Biophys Acta; 1984 Sep; 805(1):30-6. PubMed ID: 6089913
[TBL] [Abstract][Full Text] [Related]
27. Effects of nedocromil sodium on in vitro induced migration, activation, and mediator release from human granulocytes.
Bruijnzeel PL; Warringa RA; Kok PT; Hamelink ML; Kreukniet H; Koenderman L
J Allergy Clin Immunol; 1993 Jul; 92(1 Pt 2):159-64. PubMed ID: 8393021
[TBL] [Abstract][Full Text] [Related]
28. Effects of auranofin on leukotriene production and leukotriene stimulated neutrophil function.
Hafström I; Ringertz B; Palmblad J; Malmsten C
Agents Actions; 1984 Dec; 15(5-6):551-5. PubMed ID: 6099693
[TBL] [Abstract][Full Text] [Related]
29. Stimulation of human polymorphonuclear leukocytes by leukotriene B4 and platelet-activating factor: an ultrastructural and pharmacological study.
Rossi AG; MacIntyre DE; Jones CJ; McMillan RM
J Leukoc Biol; 1993 Feb; 53(2):117-25. PubMed ID: 8383164
[TBL] [Abstract][Full Text] [Related]
30. Evidence for 5, 12-dihydroxy-6,8,10,14-eicosatetraenoate as a mediator of human neutrophil aggregation.
O'Flaherty JT; Hammett MJ; Shewmake TB; Wykle RL; Love SH; McCall CE; Thomas MJ
Biochem Biophys Res Commun; 1981 Nov; 103(2):552-8. PubMed ID: 6277309
[No Abstract] [Full Text] [Related]
31. Effect of terfenadine on neutrophil and eosinophil chemotactic activities after inhalation of platelet-activating factor in vivo and on neutrophil chemotaxis in vitro.
Okada C; Hopp RJ; Miyagawa H; Sugiyama H; Nair NM; Bewtra AK; Townley RG
Int Arch Allergy Immunol; 1992; 97(3):181-6. PubMed ID: 1587633
[TBL] [Abstract][Full Text] [Related]
32. Relation to chemotactic factor gradients to neutrophil migration and orientation under agarose.
Udén AM; Hafström I; Palmblad J
J Leukoc Biol; 1986 Jan; 39(1):27-35. PubMed ID: 3001211
[TBL] [Abstract][Full Text] [Related]
33. Contrasting responses to multiple chemotactic stimuli in transendothelial migration: heterologous desensitization in neutrophils and augmentation of migration in eosinophils.
Kitayama J; Carr MW; Roth SJ; Buccola J; Springer TA
J Immunol; 1997 Mar; 158(5):2340-9. PubMed ID: 9036983
[TBL] [Abstract][Full Text] [Related]
34. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
Wardlaw AJ; Moqbel R; Cromwell O; Kay AB
J Clin Invest; 1986 Dec; 78(6):1701-6. PubMed ID: 3023451
[TBL] [Abstract][Full Text] [Related]
35. Pertussis toxin shows distinct early signalling events in platelet-activating factor-, leukotriene B4-, and C5a-induced eosinophil homotypic aggregation in vitro and recruitment in vivo.
Teixeira MM; Giembycz MA; Lindsay MA; Hellewell PG
Blood; 1997 Jun; 89(12):4566-73. PubMed ID: 9192781
[TBL] [Abstract][Full Text] [Related]
36. New method for the measurement of eosinophil migration.
Håkansson L; Westerlund D; Venge P
J Leukoc Biol; 1987 Dec; 42(6):689-96. PubMed ID: 2445885
[TBL] [Abstract][Full Text] [Related]
37. Specific inhibition of leukotriene B4-induced neutrophil activation by LY223982.
Jackson WT; Boyd RJ; Froelich LL; Mallett BE; Gapinski DM
J Pharmacol Exp Ther; 1992 Dec; 263(3):1009-14. PubMed ID: 1335049
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of neutrophil and eosinophil chemotactic responses to PAF by the PAF-antagonists WEB-2086, L-652,731, and SRI-63441.
Håkansson L; Venge P
J Leukoc Biol; 1990 May; 47(5):449-56. PubMed ID: 2335754
[TBL] [Abstract][Full Text] [Related]
39. Desensitization of acute inflammatory lesions to chemotaxins and endotoxin.
Colditz IG; Movat HZ
J Immunol; 1984 Oct; 133(4):2163-8. PubMed ID: 6088633
[TBL] [Abstract][Full Text] [Related]
40. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells.
Colotta F; Orlando S; Fadlon EJ; Sozzani S; Matteucci C; Mantovani A
J Exp Med; 1995 Jun; 181(6):2181-6. PubMed ID: 7760005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
